Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Epizyme
Epizyme
Epizyme: The Ugly Duckling Of The 2014 Biotech Rally?
Seeking Alpha
Fri, 01/2/15 - 10:30 am
Epizyme
Epizyme Gains on Positive Phase I Data on EPZ-6438
Yahoo/Zacks
Sat, 11/22/14 - 10:27 am
Epizyme
EPZ-6438
non-Hodgkin B-cell lymphoma
Biotech Stocks Get Turbo Boost From Idenix Deal
Seeking Alpha
Thu, 06/12/14 - 09:33 am
M&A
Merck
Idenix
Achillion
Agios
Alkermes
Celldex Therapeutics
Vertex
Seattle Genetics
Epizyme
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin
Seeking Alpha
Tue, 01/28/14 - 11:19 am
Cellceutix
Brilacidin
Kevetrin
Cubist Pharmaceuticals
Epizyme
Geron
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Sat, 01/11/14 - 10:13 am
Neurocrine
Intercept Pharma
Epizyme
Sangamo BioSciences
OncoMed
Zogenix
Macrogenics
Intrexon
Pharmacyclics
Galena Biopharma
Valeant Dreams Big; Cancer Drug News Lifts Pharmacyclics
Yahoo/Investors Business Daily
Wed, 01/8/14 - 08:05 am
Valeant Pharmaceuticals
Pharmacyclics
Imbruvica
Celgene
EPZ-5676
Epizyme
Keep an Eye on Pacific Biosciences, Epizyme, and Merrimack Today
Motley Fool
Fri, 11/22/13 - 10:21 am
Pacific Biosciences
Epizyme
Merrimack Pharmaceuticals
This Week in Biotech
Motley Fool
Sat, 11/16/13 - 01:23 pm
Vanda
Cadence Pharmaceuticals
Immunogen
Novartis
Pharmacyclics
JNJ
Epizyme
Sarepta Therapeutics
GSK
Epizyme: The Promise Of Personalized Cancer Therapy
Seeking Alpha
Mon, 09/16/13 - 11:03 am
Epizyme
personalized medicine
GSK
cancer
Eisai
epigenetics
Celgene
A Time to Test Biotechs' Strength
The Street
Sun, 08/25/13 - 11:31 am
Bluebird Bio
Epizyme
Intrexon
NanoString Technologies
LipoScience
Aratana
Heat Biologics
ONYX Pharmaceuticals
Amgen
Epizyme receives ophran drug designation for EPZ-5676
Yahoo/Fly on the Wall
Fri, 08/16/13 - 10:09 am
Epizyme
orphan drugs
EPZ-5676
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
TearLab
Array Biopharma
Furiex Pharmaceuticals
InterMune
Prosensa
Boston Scientific
Orexigen
Momenta
Ironwood
INSYS Therapeutics
Sequenom
OncoMed
Abraxis
Sarepta
Epizyme
Tesaro
Synta Pharmaceuticals
Bluebird Bio
Exelixis
Lexicon Pharmaceuticals
Intercept Pharma
GTx
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Mon, 07/15/13 - 11:58 am
Vivus
Trius Therapeutics
Prosensa
Pharmacyclics
NxStage Medical
Natus Medical
MiMedx
Merrimack Pharmaceuticals
Intuitive Surgical
InterMune
GTx
Fluidigm
Epizyme
Celldex
Astex
Analogic
Amarin
Alnylam
Alexion
AcelRx
Epizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs
Fierce Biotech
Thu, 04/18/13 - 07:01 pm
Epizyme
IPOs
R&D
cancer
Epizyme grabs $4M from partner GlaxoSmithKline
Bizjournals.com
Fri, 10/14/11 - 11:24 am
GSK
Epizyme
small molecule drugs
FierceBiotech's 2011 Fierce 15 Biotech Companies
Fierce Biotech
Wed, 09/7/11 - 11:28 am
Blueprint Medicines
Cerulean
Cerenis Therapeutics
Epizyme
Forma Therapeutics
Intrexon
Merrimack Pharmaceuticals
f-star
Pfenex
Pearl Therapeutics
Reata
Selecta
Rib-X Pharmaceuticals
Tesaro
Theraclone
Epizyme snags $206M epigenetics deal with Eisai
Fierce Biotech
Thu, 03/10/11 - 12:03 pm
Eisai
Epizyme
epigenetics
Life Sciences Deal Flows Boost Positive Mood at JPMorgan Healthcare Conference
Seeking Alpha
Sun, 01/16/11 - 11:43 am
life sciences
GSK
Epizyme
BioTie Therapies
Synosia Therapeutics
NextWave Pharmaceuticals
Rib-X Pharmaceuticals
DuPont
Danisco
Epizyme, Glaxo sign deal worth up to $650M
Bizjournals.com
Mon, 01/10/11 - 07:27 pm
Epizyme
GSK
personalized medicine
Pages
« first
‹ previous
1
2
3